Adheris Health Limited (ASX: AHE) - Share Price

- Current share price for AHE : $0.012

Adheris Health Limited (AHE, formerly Medadvisor Limited) is an ASX-listed company and is not held by any exchange traded funds (ETFs). It , is a pharmacy-driven patient engagement solution that provides personalised patient experiences to help simplify the patient medication journey.

AHE General Information ⁺

ASX Code	AHE
Website	http://adheris.com/investors
Industry/Sector	Health Care Technology
Market Cap ($M)	7
AHE Share Price	$0.012
Day High	$0.012
Day Low	$0.012
Last Close	$0.012
AHE Share Price Movement	- ( No change )

Prices as at 16:41, 29 Sep 2026

⁺Security prices are delayed by at least 20 minutes and are indicative only.

Adheris Health Limited (AHE) Upcoming Dividends & Yields

Distribution Type	Dividend	Franking	Ex-dividend date	Payment date	Current Price⁺	Price 7D Avg	Dividend Yield
Result	9¢	100%	12 Mar 2015	2 Apr 2015	-	-	-
HFResult	12.5¢	100%	10 Sep 2014	2 Oct 2014	-	-	-
Interim	8.5¢	100%	12 Mar 2014	3 Apr 2014	-	-	-

See all dividends from Adheris Health Limited (AHE) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

Adheris Health Limited (AHE) price-sensitive announcements

AHE - Adheris Health legal claim

Adheris Health Limited, trading on ASX as AHE, is engaged in a legal dispute with Mindspri

Adheris Health Limited (AHE)
31 Jul 2026 | 3:32 PM

AHE - 4Q FY26 Quarterly Activity Report and Appendix 4C

Adheris Health Limited, an Australian company, reported a significant decrease in revenue

Adheris Health Limited (AHE)
23 Jul 2026 | 9:20 AM

AHE - Q3 FY26 Results Presentation

Adheris Health Limited reported its Q3 FY26 financial results, showing a revenue of $5.4 m

Adheris Health Limited (AHE)
29 Apr 2026 | 8:45 AM

AHE - 3Q FY26 Quarterly Activity Report and Appendix 4C

Adheris Health Limited reported its Q3 FY26 results, showing a decline in operating revenu

Adheris Health Limited (AHE)
28 Apr 2026 | 8:42 AM

Adheris Health Limited (AHE) Recent ASX Announcements

Company	Sector	Market Cap ($m)	Headline	Release date/time⁺	Price at release⁺	Current price⁺	Gain/Loss
Adheris Health Limited (AHE) ORDINARY FULLY PAID	Health Care	$8	FY26 Results Presentation	1 Sep 2026 10:33AM	$0.014	$0.012	fallen by 14.29%
Adheris Health Limited (AHE) ORDINARY FULLY PAID	Health Care	$8	Change of Chief Financial Officer	31 Aug 2026 5:36PM	$0.014	$0.012	fallen by 14.29%
Adheris Health Limited (AHE) ORDINARY FULLY PAID	Health Care	$8	Adheris FY26 Results	31 Aug 2026 8:45AM	$0.014	$0.012	fallen by 14.29%
Adheris Health Limited (AHE) ORDINARY FULLY PAID	Health Care	$8	FY26 Annual Report	31 Aug 2026 8:43AM	$0.014	$0.012	fallen by 14.29%
Adheris Health Limited (AHE) ORDINARY FULLY PAID	Health Care	$8	Appendix 4G and Corporate Governance Statement	31 Aug 2026 8:40AM	$0.014	$0.012	fallen by 14.29%
Adheris Health Limited (AHE) ORDINARY FULLY PAID	Health Care	$8	Appendix 4E	31 Aug 2026 8:39AM	$0.014	$0.012	fallen by 14.29%

AHE Financial Summary

Year to Jun	NPAT	EPS	EPS chg (%)	PER	Yield (%)	Franking (%)
2026A	-$19.97	-$3.20	6.10%	0.00	0.00%	0.0%
2025A	-$16.78	-$3.00	-2,384.60%	0.00	0.00%	0.0%
2024A	$0.79	$0.10	-106.30%	203.50	0.00%	0.0%

AHE Peer Comparison

Company	Mkt Cap	EPS Growth (%)			P/E (%)			Dividend Yield (%)
Company	Mkt Cap	2024 A	2025 A	2026 A	2024 A	2025 A	2026 A	2024 A	2025 A	2026 A
4DMedical Limited (4DX)	$2,406M	1.4982	0.0000	0.0000	0.0000	0.0000	0.0000	0.00%	0.00%	0.00%
Adheris Health Limited (AHE)	$8M	0.0606	0.0000	0.0000	0.0000	0.0000	0.0000	0.00%	0.00%	0.00%
Artrya Limited (AYA)	$623M	-0.0450	0.0000	0.0000	0.0000	0.0000	0.0000	0.00%	0.00%	0.00%
Pro Medicus Limited (PME)	$16,820M	1.3034	-0.2811	0.2395	63.4858	88.3111	71.2452	0.43%	0.57%	0.71%

AHE Market Comparison

	Earnings	P/E Ratio	P/B Ratio	P/E Growth
Company	0.00	0.00	-3.16	0.00
Market	0.34	13.70	1.16	0.78
Sector	0.61	20.60	1.84	2.51

AHE Directors

Name	Position	Start Date
Mr John Ciccio	Chief Executive Officer, Managing Director	7 Nov 2025
Mr John Murray	Non-Executive Director	1 Jul 2026
Mr Lucas Merrow	Non-Executive Director	10 Aug 2021
Ms Catherine (Kate) Jane Hill	Non-Executive Director, Interim Chairman	24 May 2023

Adheris Health Limited (AHE) Changes in Directors' Interest & Trades

Date of change	Director	Buy/Sell	Security Type	Qty	Trade Price	Value
13 May 2026	CICCIO, John	Buy	Direct Shares	639,459	$0.021	$13,428.639
11 May 2026	CICCIO, John	Buy	Direct Shares	323,541	$0.021	$6,734.859
9 Mar 2026	MERROW, Lucas	Buy	Direct Shares	695,000	$0.022	$15,116.250

See all changes in directors' interest & trades for Adheris Health Limited (AHE) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

AHE Management

Name	Position
Ancila Desai	Chief Financial Officer
Lee Tamplin	Company Secretary

AHE Substantial Shareholders

Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in Adheris Health Limited (AHE). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.

Holding	Name
94,905,130 (15.19%)	Guild Group Holdings Limited
89,833,789 (14.37%)	Perennial Value Management Limited
53,986,463 (8.64%)	EBOS Group Limited
52,389,949 (8.38%)	Jencay Capital Pty Limited
43,999,999 (7.04%)	Cotiviti Services LLC
43,999,999 (7.04%)	KKR Entities

AHE Calendar of Events

Date	Event
31 August 2027	Report (Prelim)
30 August 2027	Report (Annual)
30 August 2027	Report (Prelim)
26 February 2027	Report (Interim)
08 October 2026	Report (Annual)

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.

What our members say about us